跳至主要内容
临床试验/NL-OMON28285
NL-OMON28285招募中不适用

MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with Polycystic Ovary Syndrome: a multicentre double-blind randomised controlled trial

Erasmus MC, University Medical Center Rotterdam0 个研究点目标入组 464 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
464

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • = 18 years of age
  • - Diagnosis of PCOS according to the Rotterdam consensus criteria and confirmed by a gynaecologist
  • - A viable singleton pregnancy confirmed by ultrasound
  • - Being able to initiate the use of study supplements between 8+0 and 16+0 weeks gestational age
  • - Ability to understand Dutch or English
  • - Ability to provide written informed consent

排除标准

  • - Diagnosis of pre-existent type-1 or 2 diabetes mellitus
  • - Pre-existent renal failure, defined as an estimated glomerular filtration rate (eGFR) less than 50 ml/min/1.73m2
  • - Use of myo-inositol supplements, other insulin-mimetics, hypoglycaemic agents (e.g. metformin) and/or systemic steroids, that cannot be discontinued at the time of inclusion

研究者

发起方
Erasmus MC, University Medical Center Rotterdam

相似试验